Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Author(s): Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
Issue: Jul/Aug 1999 - Compounding Parenteral Products
View All Articles in Issue
Page(s): 316-320
Download in electronic PDF format for $75
Abstract: The stability of amphotericin B 5 mg/mL in 5% dextrose
ophthalmic solution prepared by the Hospital Pharmacy Service
was studied in different conditions of storage and use.
Admixtures of amphotericin B were aseptically prepared in
low-density polyethylene dropper bottles. The stability of amphotericin
B was evaluated in ophthalmic dropper bottles stored
in a refrigerator, at room temperature, protected from, or exposed
to, light. To simulate the effect of exposure to air, some
ophthalmic dropper bottles were opened twice daily and two
drops were removed. Immediately after preparation, samples
were collected to determine the initial drug concentration by
high-performance liquid chromatography and to assess pH,
osmolality and sterility. The same tests were conducted after
four, eight and 15 days of storage in ophthalmic containers
opened daily and unopened after eight, 15, 30, 60, 75 and 120
days of storage. Samples were visually inspected daily for
signs of physical incompatibility. An additional study was
conducted in four ophthalmic containers collected in the
ophthalmology unit after eight or 15 days of current patient
use testing the same parameters. Ophthalmic containers stored
in the refrigerator (the closed and the opened daily set) showed
no loss or deterioration of amphotericin B during the corresponding
period of storage (120 and 15 days, respectively).
We observed precipitation and degradation after 13 days of
storage in ophthalmic containers exposed to normal lighting
conditions at room temperature, and after 16 days in ophthalmic
containers protected from light. There was no appreciable
change in pH or osmolality in any of the samples.
Microbiological investigation disclosed negative culture results
for all samples. This study shows that aseptically prepared
amphotericin B ophthalmic solution packaged in low-density
polyethylene bottles can be stored safely for up to 120 days
when unopened and stored at 4°C and protected from light,
for 16 days when stored at 22°C and protected from light and
for 13 days when stored at 22°C and exposed to light.
Related Keywords:
amphotericin B, degradation, ophtalmic solution, osmolality, pH, precipitation
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
|
Jul/Aug 1999
Pg. 316-320
|
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L, Kokki H, Rasi A S, Naaranlahti Toivo J
|
Nov/Dec 2002
Pg. 471-474
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 122-125
|
Amphotericin B 2-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 1998
Pg. 223
|
Amphotericin B 2-mg/mL Ophthalmic Solution
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 185
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Kommanaboyina Brahmaiah, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
|
Mar/Apr 2000
Pg. 146-149
|
Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
|
Mar/Apr 2006
Pg. 156-158
|
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
|
Sep/Oct 2015
Pg. 367-373
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 422
|
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 65
|
Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
|
Jan/Feb 2009
Pg. 53-55
|
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S, Kaushik Sarita
|
Mar/Apr 2004
Pg. 147-152
|
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 324
|
Return to Top |